ClinicalTrials.gov
public full text
Public Domain
Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease.#645238
- Better Classification of Respiratory Amyloidosis#1140994
- Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors#1030970
- Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01#303736
- Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma#1173188
Record · ID 287395
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive